Use of Infliximab for the Treatment of Pemphigus Vulgaris
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Woodley, MD
Department of Dermatology, Norris Cancer Center, University of Southern California
Principal Investigator - E. William St. Clair, MD
Division of Rheumatology and Immunology, Duke University Medical Center
Study Chair - Garnett Kelsoe, DSci
Department of Immunology, Duke University
Principal Investigator - Janet Fairley, MD
Department of Dermatology, University of Iowa
Principal Investigator - Russell P. Hall, MD
Division of Dermatology, Duke University Medical Center
Study Chair - Victoria Werth, MD
Department of Dermatology, University of Pennsylvania School of Medicine
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Norris Cancer Center, University of Southern California
Los Angeles, California, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 31 Dec 2010
- Completion
- 31 Mar 2011
- Last update posted
- 6 Dec 2017
- Registered enrollment
- 20
- Registry id
- NCT00283712
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.